Defining synchronous oligometastatic non-small cell lung cancer: a systematic review.
暂无分享,去创建一个
V. Durieux | A. Dingemans | S. Novello | T. Berghmans | B. Besse | A. Levy | B. Hasan | L. Hendriks | M. G. Levra | Niccolo Giajlevra
[1] P. V. Van Schil,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] C. Dooms,et al. MA25.03 Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion , 2018, Journal of Thoracic Oncology.
[3] N. Girard,et al. MA25.02 Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts , 2018, Journal of Thoracic Oncology.
[4] N. Girard,et al. MA25.01 EORTC Lung Cancer Group Survey to Define Synchronous Oligometastatic Disease in NSCLC , 2018, Journal of Thoracic Oncology.
[5] B. V. Van Beers,et al. Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group. , 2018, European journal of cancer.
[6] S. Volpi,et al. The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer. , 2018, Annals of translational medicine.
[7] P. Iyengar,et al. Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial , 2018, JAMA oncology.
[8] F. Alongi,et al. Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. , 2017, Journal of thoracic disease.
[9] Ming Chen,et al. Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies , 2016, BMC Cancer.
[10] J. Lee,et al. Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study , 2016, The Lancet. Oncology.
[11] Henry Knipe,et al. Oligometastases , 2016, Radiopaedia.org.
[12] D. Boffa,et al. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer. , 2016, The Annals of thoracic surgery.
[13] Y. Nishimura,et al. Clinical outcome of node‐negative oligometastatic non–small cell lung cancer , 2016, Thoracic cancer.
[14] C. Rübe,et al. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer , 2016, BMC Cancer.
[15] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[16] S Senan,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] Ming Chen,et al. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China. , 2015, International journal of radiation oncology, biology, physics.
[18] C. Simone,et al. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. , 2015, Practical radiation oncology.
[19] D. Gomez,et al. Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy. , 2014, International journal of radiation oncology, biology, physics.
[20] C. Nieder,et al. Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers? , 2014, Medical Principles and Practice.
[21] Ravi B. Parikh,et al. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. , 2014, International journal of radiation oncology, biology, physics.
[22] B. Yaremko,et al. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. , 2013, Lung cancer.
[23] B. Passlick,et al. Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer , 2015, Indian Journal of Surgery.
[24] R. Stahel,et al. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. , 2012, Lung cancer.
[25] P. Lambin,et al. Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] D. Gomez,et al. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. , 2012, International journal of radiation oncology, biology, physics.
[27] G. Apolone,et al. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience. , 2012, The Journal of thoracic and cardiovascular surgery.
[28] P. Okunieff,et al. Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer , 2011, Radiation oncology.
[29] R. Onimaru,et al. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. , 2010, Japanese journal of clinical oncology.
[30] R. Abrams,et al. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] M. Kris,et al. A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. , 2002, Lung cancer.